Skip to main content
Top
Published in: BMC Gastroenterology 1/2013

Open Access 01-12-2013 | Research article

Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions

Authors: Polyxeni P Doumba, Marilena Nikolopoulou, Ilias P Gomatos, Manousos M Konstadoulakis, John Koskinas

Published in: BMC Gastroenterology | Issue 1/2013

Login to get access

Abstract

Background

Many studies have suggested that the immune response may play a crucial role in the progression of hepatocellular carcinoma (HCC). Therefore, our aim was to establish a (i) functional culture of primary human tumor hepatocytes and non-tumor from patients with hepatocellular carcinoma (HCC) and (ii) a co-culture system of HCC and non-HCC hepatocytes with autologous peripheral blood mononuclear cells (PBMCs) in order to study in vitro cell-to-cell interactions.

Methods

Tumor (HCC) and non-tumor (non-HCC) hepatocytes were isolated from the liver resection specimens of 11 patients operated for HCC, while PBMCs were retrieved immediately prior to surgery. Four biopsies were obtained from patients with no liver disease who had surgery for non malignant tumor (normal hepatocytes). Hepatocytes were either cultured alone (monoculture) or co-cultured with PBMCs. Flow cytometry measurements for MHC class II expression, apoptosis, necrosis and viability (7AAD) were performed 24 h, 48 h and 72 h in co-culture and monocultures.

Results

HCC and non-HCC hepatocytes exhibited increased MHC-II expression at 48h and 72h in co-culture with PBMCs as compared to monoculture, with MHC II-expressing HCC hepatocytes showing increased viability at 72 h. PBMCs showed increased MHC-II expression (activation) in co-culture with HCC as compared to non-HCC hepatocytes at all time points. Moreover, CD8+ T cells had significantly increased apoptosis and necrosis at 48h in co-culture with HCC hepatocytes as compared to monocultures. Interestingly, MHC-II expression on both HCC and non-HCC hepatocytes in co-culture was positively correlated with the respective activated CD8+ T cells.

Conclusions

We have established an in vitro co-culture model to study interactions between autologous PBMCs and primary HCC and non-HCC hepatocytes. This direct interaction leads to increased antigen presenting ability of HCC hepatocytes, activation of PBMCs with a concomitant apoptosis of activated CD8+ T cells. Although, a partially effective immune response against HCC exists, still tumor hepatocytes manage to escape.
Appendix
Available only for authorised users
Literature
1.
go back to reference Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF: Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res. 2004, 10: 4332-4341. 10.1158/1078-0432.CCR-04-0181.CrossRefPubMed Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF: Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res. 2004, 10: 4332-4341. 10.1158/1078-0432.CCR-04-0181.CrossRefPubMed
2.
go back to reference Mizukoshi E, Nakamoto Y, Marukawa Y, Arai K, Yamashita T, Tsuji H, Kuzushima K, Takiguchi M, Kaneko S: Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology. 2006, 43: 1284-1294. 10.1002/hep.21203.CrossRefPubMed Mizukoshi E, Nakamoto Y, Marukawa Y, Arai K, Yamashita T, Tsuji H, Kuzushima K, Takiguchi M, Kaneko S: Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology. 2006, 43: 1284-1294. 10.1002/hep.21203.CrossRefPubMed
3.
go back to reference Liu Y, Daley S, Evdokimova VN, Zdobinski DD, Potter DM, Butterfield LH: Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. J Immunol. 2006, 177: 712-721.CrossRefPubMedPubMedCentral Liu Y, Daley S, Evdokimova VN, Zdobinski DD, Potter DM, Butterfield LH: Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. J Immunol. 2006, 177: 712-721.CrossRefPubMedPubMedCentral
4.
go back to reference Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M: Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998, 27: 407-417. 10.1002/hep.510270214.CrossRefPubMed Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M: Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998, 27: 407-417. 10.1002/hep.510270214.CrossRefPubMed
5.
go back to reference Pang YL, Zhang HG, Peng JR, Pang XW, Yu S, Xing Q, Yu X, Gong L, Yin YH, Zhang Y, Chen WF: The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunol Immunother. 2009, 58: 877-886. 10.1007/s00262-008-0603-5.CrossRefPubMed Pang YL, Zhang HG, Peng JR, Pang XW, Yu S, Xing Q, Yu X, Gong L, Yin YH, Zhang Y, Chen WF: The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunol Immunother. 2009, 58: 877-886. 10.1007/s00262-008-0603-5.CrossRefPubMed
6.
go back to reference Zou W: Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat Rev Cancer. 2005, 5: 263-274.CrossRefPubMed Zou W: Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat Rev Cancer. 2005, 5: 263-274.CrossRefPubMed
7.
go back to reference Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C: Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol. 1998, 28: 221-236. 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO;2-F.CrossRefPubMed Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C: Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol. 1998, 28: 221-236. 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO;2-F.CrossRefPubMed
8.
go back to reference Bertolino P, Trescol-Biémont MC, Thomas J, Fazekas de St Groth B, Pihlgren M, Marvel J, Rabourdin-Combe C: Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol. 1999, 11: 1225-1238. 10.1093/intimm/11.8.1225.CrossRefPubMed Bertolino P, Trescol-Biémont MC, Thomas J, Fazekas de St Groth B, Pihlgren M, Marvel J, Rabourdin-Combe C: Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol. 1999, 11: 1225-1238. 10.1093/intimm/11.8.1225.CrossRefPubMed
9.
go back to reference Herkel J, Jagemann B, Wiegard C, Lazaro JFG, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW: MHC Class II–expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology. 2003, 37: 1079-1085. 10.1053/jhep.2003.50191.CrossRefPubMed Herkel J, Jagemann B, Wiegard C, Lazaro JFG, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW: MHC Class II–expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology. 2003, 37: 1079-1085. 10.1053/jhep.2003.50191.CrossRefPubMed
10.
go back to reference Paterson AC, Sciot R, Kew M, Callea CF, Dusheiko GM, Desmet VJ: HLA expression in human hepatocellular carcinoma cells. Br J Cancer. 1988, 57: 369-373. 10.1038/bjc.1988.84.CrossRefPubMedPubMedCentral Paterson AC, Sciot R, Kew M, Callea CF, Dusheiko GM, Desmet VJ: HLA expression in human hepatocellular carcinoma cells. Br J Cancer. 1988, 57: 369-373. 10.1038/bjc.1988.84.CrossRefPubMedPubMedCentral
11.
go back to reference Sung CH, Hu C, Hsu HC Ng AK, Chou CK, Ting LP, Su TS, Han SH, Changet CM: Expression of class I and class II Major histocompatibility antigens on human hepatocellular carcinoma. J Clin Invest. 1989, 83: 421-429. 10.1172/JCI113900.CrossRefPubMedPubMedCentral Sung CH, Hu C, Hsu HC Ng AK, Chou CK, Ting LP, Su TS, Han SH, Changet CM: Expression of class I and class II Major histocompatibility antigens on human hepatocellular carcinoma. J Clin Invest. 1989, 83: 421-429. 10.1172/JCI113900.CrossRefPubMedPubMedCentral
12.
go back to reference Krief PB, Azzarone B, Boucheix C: Different levels of interferon-γ induction of class I and class II major histocompatibility antigens in human hepatoma cell lines. Viral Hepatitis and Liver Disease. Edited by: Alan R. 1988, New York: Liss Inc, 217- Krief PB, Azzarone B, Boucheix C: Different levels of interferon-γ induction of class I and class II major histocompatibility antigens in human hepatoma cell lines. Viral Hepatitis and Liver Disease. Edited by: Alan R. 1988, New York: Liss Inc, 217-
13.
go back to reference Hsu HC, Sheu JC, Lin YH: Prognostic histologic features in restricted small hepatocellular carcinoma (HCC) I Tawain: a comparison with resected large HCC. Cancer. 1985, 56: 672-680. 10.1002/1097-0142(19850801)56:3<672::AID-CNCR2820560340>3.0.CO;2-V.CrossRefPubMed Hsu HC, Sheu JC, Lin YH: Prognostic histologic features in restricted small hepatocellular carcinoma (HCC) I Tawain: a comparison with resected large HCC. Cancer. 1985, 56: 672-680. 10.1002/1097-0142(19850801)56:3<672::AID-CNCR2820560340>3.0.CO;2-V.CrossRefPubMed
14.
go back to reference Takagi S, Chen K, Schwarz R, Shunzaburo I, Heberman RB, Whiteside TL: Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2. Cancer. 1989, 63: 102-111. 10.1002/1097-0142(19890101)63:1<102::AID-CNCR2820630117>3.0.CO;2-T.CrossRefPubMed Takagi S, Chen K, Schwarz R, Shunzaburo I, Heberman RB, Whiteside TL: Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2. Cancer. 1989, 63: 102-111. 10.1002/1097-0142(19890101)63:1<102::AID-CNCR2820630117>3.0.CO;2-T.CrossRefPubMed
15.
go back to reference Paroli M, Perrone A, Bonavita MS, Barnaba V: Immunology of hepatocellular carcinoma. Ital J Gastroenterol. 1991, 23: 494-497.PubMed Paroli M, Perrone A, Bonavita MS, Barnaba V: Immunology of hepatocellular carcinoma. Ital J Gastroenterol. 1991, 23: 494-497.PubMed
16.
go back to reference Serti E, Doumba PP, Thyphronitis G, Tsitoura P, Katsarou K, Foka P, Konstandoulakis MM, Koskinas J, Mavromara P, Georgopoulou U: Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cell Mol Life Sci. 2011, 68: 505-522. 10.1007/s00018-010-0466-8.CrossRefPubMed Serti E, Doumba PP, Thyphronitis G, Tsitoura P, Katsarou K, Foka P, Konstandoulakis MM, Koskinas J, Mavromara P, Georgopoulou U: Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cell Mol Life Sci. 2011, 68: 505-522. 10.1007/s00018-010-0466-8.CrossRefPubMed
17.
go back to reference Thornton AJ, Ham J, Kunkel SL: Kupffer Cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology. 1992, 15: 1112-1122. 10.1002/hep.1840150623.CrossRef Thornton AJ, Ham J, Kunkel SL: Kupffer Cell-derived cytokines induce the synthesis of a leukocyte chemotactic peptide, interleukin-8, in human hepatoma and primary hepatocyte cultures. Hepatology. 1992, 15: 1112-1122. 10.1002/hep.1840150623.CrossRef
18.
go back to reference Gehring AJ, Sun D, Kennedy PTF, Nolte-’t Hoen E, Lim SG, Wasser S, Selden C, Maini MK, Davis DM, Nassal M, Bertoletti A: The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol. 2007, 81: 2940-2949. 10.1128/JVI.02415-06.CrossRefPubMedPubMedCentral Gehring AJ, Sun D, Kennedy PTF, Nolte-’t Hoen E, Lim SG, Wasser S, Selden C, Maini MK, Davis DM, Nassal M, Bertoletti A: The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol. 2007, 81: 2940-2949. 10.1128/JVI.02415-06.CrossRefPubMedPubMedCentral
19.
go back to reference Wigmore SJ, Fearon KCH, Maingay JP, Lai PBS, Ross JA: Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol Endocrinol Metab. 1997, 273: 720-726. Wigmore SJ, Fearon KCH, Maingay JP, Lai PBS, Ross JA: Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol Endocrinol Metab. 1997, 273: 720-726.
20.
go back to reference Foka P, Pourchet A, Hernandez-Alcoceba R, Doumba PP, Pissas G, Kouvatsis V, Dalagiorgou G, Kazazi D, Marconi P, Foschini M, Manservigi R, Konstadoulakis MM, Koskinas J, Epstein AL, Mavromara P: Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors. J Gene Med. 2010, 12: 956-67. 10.1002/jgm.1519.CrossRefPubMed Foka P, Pourchet A, Hernandez-Alcoceba R, Doumba PP, Pissas G, Kouvatsis V, Dalagiorgou G, Kazazi D, Marconi P, Foschini M, Manservigi R, Konstadoulakis MM, Koskinas J, Epstein AL, Mavromara P: Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors. J Gene Med. 2010, 12: 956-67. 10.1002/jgm.1519.CrossRefPubMed
21.
go back to reference Wu J, Wang C, Liu Q, Yang T, Zhang Q, Peng J, Gao Y, Sun H, Kaku T, Liu K: Protective effect of JBP485 on concanavalin A-induced hepatocyte toxicity in primary cultured rat hepatocytes. Eur J Pharmacol. 2008, 589: 299-305. 10.1016/j.ejphar.2008.04.066.CrossRefPubMed Wu J, Wang C, Liu Q, Yang T, Zhang Q, Peng J, Gao Y, Sun H, Kaku T, Liu K: Protective effect of JBP485 on concanavalin A-induced hepatocyte toxicity in primary cultured rat hepatocytes. Eur J Pharmacol. 2008, 589: 299-305. 10.1016/j.ejphar.2008.04.066.CrossRefPubMed
22.
go back to reference Jiang X, Gregory SH, Wing EJ: Immune CD8+ T lymphocytes lyse Listeria monocytogenes-infected hepatocytes by a classical MHC class I-restricted mechanism. J Immunol. 1997, 158: 287-293.PubMed Jiang X, Gregory SH, Wing EJ: Immune CD8+ T lymphocytes lyse Listeria monocytogenes-infected hepatocytes by a classical MHC class I-restricted mechanism. J Immunol. 1997, 158: 287-293.PubMed
23.
go back to reference Salgado FJ, Lojo J, Fernández-Alonso CM, Viñuela J, Cordero OJ, Nogueira M: Interleukin-dependent modulation of HLA-DR expression on CD4and CD8 activated T cells. Immunol Cell Biol. 2002, 80: 138-47. 10.1046/j.1440-1711.2002.01055.x.CrossRefPubMed Salgado FJ, Lojo J, Fernández-Alonso CM, Viñuela J, Cordero OJ, Nogueira M: Interleukin-dependent modulation of HLA-DR expression on CD4and CD8 activated T cells. Immunol Cell Biol. 2002, 80: 138-47. 10.1046/j.1440-1711.2002.01055.x.CrossRefPubMed
24.
go back to reference Ramadori G, Moebius U, Dienes HP, Meuer S, Meyer zum Büschenfelde KH: Lymphocytes from hepatic inflammatory infiltrate kill rat hepatocytes in primary culture. Comparison with peripheral blood lymphocytes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990, 59: 263-270. 10.1007/BF02899413.CrossRefPubMed Ramadori G, Moebius U, Dienes HP, Meuer S, Meyer zum Büschenfelde KH: Lymphocytes from hepatic inflammatory infiltrate kill rat hepatocytes in primary culture. Comparison with peripheral blood lymphocytes. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990, 59: 263-270. 10.1007/BF02899413.CrossRefPubMed
25.
go back to reference Natali PG, Giacomini P, Bigotir A, Imai K, Nicotra MR, Ng AK, Ferrone S: Heterogeneity in the expression of HLA and tumour associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res. 1983, 43: 660-668.PubMed Natali PG, Giacomini P, Bigotir A, Imai K, Nicotra MR, Ng AK, Ferrone S: Heterogeneity in the expression of HLA and tumour associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res. 1983, 43: 660-668.PubMed
26.
go back to reference Goodenow RS, Vogel JM, Linsk RL: Histocompatibility antigens on murine tumors. Science. 1985, 230: 777-783. 10.1126/science.2997918.CrossRefPubMed Goodenow RS, Vogel JM, Linsk RL: Histocompatibility antigens on murine tumors. Science. 1985, 230: 777-783. 10.1126/science.2997918.CrossRefPubMed
27.
go back to reference Festenstein H, Garrido F: MHC antigens and malignancy. Nature. 1986, 322: 502-503. 10.1038/322502a0.CrossRefPubMed Festenstein H, Garrido F: MHC antigens and malignancy. Nature. 1986, 322: 502-503. 10.1038/322502a0.CrossRefPubMed
28.
go back to reference Bateman WJ, Jenkinson E, Owen J: T-cell immunity to murine Moloney sarcoma virus-induced tumors: L3T4 T cells are necessary for resistance to primary sarcoma growth, but Lyt-2 cells are required for resistance to secondary tumour cell challenge. Immunology. 1987, 61: 317-320.PubMedPubMedCentral Bateman WJ, Jenkinson E, Owen J: T-cell immunity to murine Moloney sarcoma virus-induced tumors: L3T4 T cells are necessary for resistance to primary sarcoma growth, but Lyt-2 cells are required for resistance to secondary tumour cell challenge. Immunology. 1987, 61: 317-320.PubMedPubMedCentral
29.
go back to reference Greenberg P: Requirements for antigen-specific induction and expression of CD4 and CD8 T-cell responses to tumors. Cellular Immunity and the Immunotherapy of Cancer. Edited by: Lotze M, Finn O. 1990, New York: Wiley-Liss, 235- Greenberg P: Requirements for antigen-specific induction and expression of CD4 and CD8 T-cell responses to tumors. Cellular Immunity and the Immunotherapy of Cancer. Edited by: Lotze M, Finn O. 1990, New York: Wiley-Liss, 235-
30.
go back to reference Hammerling GJ, Klar D, Pulm W, Momburg F, Moldenhauer G: The influence of major histocompatability complex class I antigens on tumor growth and metastasis. Biochim Biophys Acta. 1987, 907: 245-259.PubMed Hammerling GJ, Klar D, Pulm W, Momburg F, Moldenhauer G: The influence of major histocompatability complex class I antigens on tumor growth and metastasis. Biochim Biophys Acta. 1987, 907: 245-259.PubMed
31.
go back to reference Tanaka K, Hayashi H, Hamada C, Khoury G, Jay G: Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells. Proc Natl Acad Sci USA. 1986, 83: 8723-8727. 10.1073/pnas.83.22.8723.CrossRefPubMedPubMedCentral Tanaka K, Hayashi H, Hamada C, Khoury G, Jay G: Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells. Proc Natl Acad Sci USA. 1986, 83: 8723-8727. 10.1073/pnas.83.22.8723.CrossRefPubMedPubMedCentral
32.
go back to reference Wallich R, Bulbuc M, Hammerling G, Katzav S, Segal S, Feldman M: Abrogation of metastatic properties of tumour cells by the novo expression of H-2K antigens following H-2 gene transfection. Nature. 1985, 315: 301-305. 10.1038/315301a0.CrossRefPubMed Wallich R, Bulbuc M, Hammerling G, Katzav S, Segal S, Feldman M: Abrogation of metastatic properties of tumour cells by the novo expression of H-2K antigens following H-2 gene transfection. Nature. 1985, 315: 301-305. 10.1038/315301a0.CrossRefPubMed
33.
go back to reference Gopas J, Roger-Zisman B, Hammerling GJ, Segal S: The relationship between MHC gene expression and metastasis. Adv Cancer Res. 1989, 53: 89-115.CrossRefPubMed Gopas J, Roger-Zisman B, Hammerling GJ, Segal S: The relationship between MHC gene expression and metastasis. Adv Cancer Res. 1989, 53: 89-115.CrossRefPubMed
34.
go back to reference Dienes HP, Hutteroth T, Hess G, Meuer SC: Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology. 1987, 7: 1317-1325. 10.1002/hep.1840070623.CrossRefPubMed Dienes HP, Hutteroth T, Hess G, Meuer SC: Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B. Hepatology. 1987, 7: 1317-1325. 10.1002/hep.1840070623.CrossRefPubMed
35.
go back to reference Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology. 1988, 8: 449-454. 10.1002/hep.1840080302.CrossRefPubMed Franco A, Barnaba V, Natali P, Balsano C, Musca A, Balsano F: Expression of class I and class II major histocompatibility complex antigens on human hepatocytes. Hepatology. 1988, 8: 449-454. 10.1002/hep.1840080302.CrossRefPubMed
36.
go back to reference Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P: The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest. 2004, 114: 701-712.CrossRefPubMedPubMedCentral Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P: The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest. 2004, 114: 701-712.CrossRefPubMedPubMedCentral
37.
go back to reference Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 1998, 396: 699-703. 10.1038/25387.CrossRefPubMed Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D, Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 1998, 396: 699-703. 10.1038/25387.CrossRefPubMed
38.
go back to reference Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJM: Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005, 41: 722-730. 10.1002/hep.20644.CrossRefPubMed Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJM: Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005, 41: 722-730. 10.1002/hep.20644.CrossRefPubMed
Metadata
Title
Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions
Authors
Polyxeni P Doumba
Marilena Nikolopoulou
Ilias P Gomatos
Manousos M Konstadoulakis
John Koskinas
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2013
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-13-17

Other articles of this Issue 1/2013

BMC Gastroenterology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.